JP2023535453A5 - - Google Patents

Info

Publication number
JP2023535453A5
JP2023535453A5 JP2023504746A JP2023504746A JP2023535453A5 JP 2023535453 A5 JP2023535453 A5 JP 2023535453A5 JP 2023504746 A JP2023504746 A JP 2023504746A JP 2023504746 A JP2023504746 A JP 2023504746A JP 2023535453 A5 JP2023535453 A5 JP 2023535453A5
Authority
JP
Japan
Prior art keywords
alkyl
aryl
heteroaryl
pharmaceutically acceptable
stereoisomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023504746A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023535453A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/042999 external-priority patent/WO2022020730A1/en
Publication of JP2023535453A publication Critical patent/JP2023535453A/ja
Publication of JP2023535453A5 publication Critical patent/JP2023535453A5/ja
Pending legal-status Critical Current

Links

JP2023504746A 2020-07-24 2021-07-23 キナゾリノンhsd17b13阻害剤とその使用 Pending JP2023535453A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063056168P 2020-07-24 2020-07-24
US63/056,168 2020-07-24
US202063113557P 2020-11-13 2020-11-13
US63/113,557 2020-11-13
PCT/US2021/042999 WO2022020730A1 (en) 2020-07-24 2021-07-23 Quinazolinone hsd17b13 inhibitors and uses thereof

Publications (2)

Publication Number Publication Date
JP2023535453A JP2023535453A (ja) 2023-08-17
JP2023535453A5 true JP2023535453A5 (cg-RX-API-DMAC7.html) 2024-07-18

Family

ID=79728363

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023504746A Pending JP2023535453A (ja) 2020-07-24 2021-07-23 キナゾリノンhsd17b13阻害剤とその使用

Country Status (10)

Country Link
US (1) US20230286923A1 (cg-RX-API-DMAC7.html)
EP (1) EP4185380A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023535453A (cg-RX-API-DMAC7.html)
KR (1) KR20230066554A (cg-RX-API-DMAC7.html)
CN (1) CN116194440A (cg-RX-API-DMAC7.html)
AU (1) AU2021310936A1 (cg-RX-API-DMAC7.html)
CA (1) CA3186951A1 (cg-RX-API-DMAC7.html)
IL (1) IL300107A (cg-RX-API-DMAC7.html)
TW (1) TW202220964A (cg-RX-API-DMAC7.html)
WO (1) WO2022020730A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN202011027502A (cg-RX-API-DMAC7.html) * 2020-06-29 2021-12-31 Council Scient Ind Res
JP2023537271A (ja) 2020-07-24 2023-08-31 イニファーム,インク. チオフェンhsd17b13阻害剤とその使用
CN116670118B (zh) 2020-11-13 2026-02-06 伊尼制药公司 二氯苯酚hsd17b13抑制剂及其用途
US12617772B2 (en) * 2021-04-05 2026-05-05 Inipharm, Inc. Hydroxypyridine HSD17B13 inhibitors and uses thereof
CA3229569A1 (en) 2021-08-20 2023-02-23 Enanta Pharmaceuticals, Inc. 17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereof
WO2023192375A1 (en) * 2022-03-29 2023-10-05 Fl2022-001, Inc. Hsd17b13 inhibitors and uses thereof
CN114644655B (zh) * 2022-04-19 2023-10-27 湖南农业大学 一种光催化磷酰化喹唑啉酮类化合物的制备方法
IL315794A (en) * 2022-04-28 2024-11-01 Enanta Pharm Inc Pyrimidine containing 17-beta-hydrosteroid dehydrogenase type 13 inhibitors
HRP20251564T1 (hr) * 2022-05-19 2026-01-30 Astrazeneca Ab Amidni heteroaromatski spojevi korisni u liječenju bolesti jetre
US20250340546A1 (en) 2022-06-09 2025-11-06 Boehringer Ingelheim International Gmbh Hsd17b13 inhibitors
WO2025024682A1 (en) * 2023-07-26 2025-01-30 Inipharm, Inc. Methods of using dichlorophenol hsd17b13 inhibitors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2694711A (en) * 1952-12-02 1954-11-16 American Cyanamid Co Quinazolone antimalarial compounds
JP2005097276A (ja) * 2003-08-22 2005-04-14 Takeda Chem Ind Ltd 縮合ピリミジン誘導体およびその用途
US20070010537A1 (en) * 2004-08-20 2007-01-11 Kazumasa Hamamura Fused pyramidine derivative and use thereof
US20090163521A1 (en) * 2005-06-28 2009-06-25 Orchid Research Laboratories Limited Novel Pyrazolopyrimidinone Derivatives
HUE035389T2 (en) * 2006-09-26 2018-05-02 Celgene Corp 5-substituted quinazolinone derivatives as anticancer agents
US20080255161A1 (en) * 2007-04-11 2008-10-16 Dmitry Koltun 3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
US20120165330A1 (en) * 2010-12-22 2012-06-28 Sirtris Pharmaceuticals, Inc. Quinazolinone and related analogs as sirtuin modulators
AU2014205043B2 (en) * 2013-01-14 2018-10-04 Deuterx, Llc 3-(5-substituted-4-oxoquinazolin-3(4h)-yl)-3-deutero-piperidine-2,6-dione derivatives
WO2016081522A1 (en) * 2014-11-17 2016-05-26 Rhode Island Hospital Nanomaterial compositions, synthesis, and assembly
EP3404024B1 (en) * 2016-01-14 2020-11-18 Kangpu Biopharmaceuticals, Ltd. Quinazolinone derivative, preparation method therefor, pharmaceutical composition, and applications

Similar Documents

Publication Publication Date Title
JP2024514223A5 (cg-RX-API-DMAC7.html)
JP2023537271A5 (cg-RX-API-DMAC7.html)
JP2024520481A5 (cg-RX-API-DMAC7.html)
JP2024543976A5 (cg-RX-API-DMAC7.html)
RU2017112048A (ru) Синергистические комбинации ауристана
RU2009109949A (ru) Соединения для лечения пролиферативных расстройств
JP2010501562A5 (cg-RX-API-DMAC7.html)
JP2021534108A5 (cg-RX-API-DMAC7.html)
RU2019100164A (ru) Гетероциклическое соединение, используемое как ингибитор fgfr
JP2019522055A5 (cg-RX-API-DMAC7.html)
JP2023553835A5 (cg-RX-API-DMAC7.html)
JP2015531773A5 (cg-RX-API-DMAC7.html)
JP2011037841A5 (cg-RX-API-DMAC7.html)
JP2011057693A5 (cg-RX-API-DMAC7.html)
JP2017537940A5 (cg-RX-API-DMAC7.html)
JP2014511840A5 (cg-RX-API-DMAC7.html)
JP2009536221A5 (cg-RX-API-DMAC7.html)
JP2025507292A5 (cg-RX-API-DMAC7.html)
AU2006272652B2 (en) 1,2,3-triazoles inhibitors of tubulin polymerization for the treatment of proliferative disorders
JP2025503953A5 (cg-RX-API-DMAC7.html)
RU2007124329A (ru) ПРОИЗВОДНЫЕ 5-ГИДРОКСИБЕНЗОТИАЗОЛА В КАЧЕСТВЕ АГОНИСТОВ β2 АДРЕНОРЕЦЕПТОРОВ
JP2012522759A5 (cg-RX-API-DMAC7.html)
RU2012109554A (ru) Лиганды сигма-рецепторов для предупреждения или лечения боли, вызванной химиотерапией
JP2017537886A5 (cg-RX-API-DMAC7.html)
JP2008517030A5 (cg-RX-API-DMAC7.html)